Non invasive biomarkers for prostate cancer
17 Apr 2012
Non invasive biomarkers for prostate cancer
Lenalidomide with melphalan + prednisone and lenalidomide maintenance for multiple myeloma
Developing twinning programs
The role of genomic testing in personalised medicine for breast cancer
Key procedures of molecular diagnosis
Cellular senescence and chromatin structure
Educating and integrating clinicians and types of care
Cellular pathways in lung cancer and the need for personalised medicine
Understanding tumour metastasis
The TOR complex and inhibitor development
Chromosome instability in cancer development
Increasing cancer survivorship with new check up procedures